Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Maximal Exercise on Matrix Metalloproteinase Enzyme and Its Inhibitor (MMP9 and TIMP1) and The Role of MMP9 -1562 C/T and TIMP1 372 T/C Polymorphisms

NCT04157556 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.

NCT NCT04157556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04157556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Maximal Exercise on Matrix Metalloproteinase Enzyme and Its Inhibitor (MMP9 and TIMP1) and The Role of MMP9 -1562 C/T and TIMP1 372 T/C Polymorphisms
Lead sponsor
Dokuz Eylul University
Phase
Not applicable
Overall status
Completed
Start date
November 11, 2019
Completion date
April 28, 2020
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mmp9, mmp9 -1562 c/t, timp1, timp1 372 t/c